Efficient Synthesis of 2-Modified 1α,25-Dihydroxy-19-norvitamin D3with Julia Olefination: High Potency in Induction of Differentiation on HL-60 Cells
- 23 August 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 68 (19) , 7407-7415
- https://doi.org/10.1021/jo034787y
Abstract
Six novel 2-substituted analogues of 1α,25-dihydroxy-19-norvitamin D3, 6a,b−8a,b, were efficiently synthesized utilizing (−)-quinic acid as the A-ring precursor. The C2-modified A-rings were prepared as 4-alkylated (3R,5R)-3,5-dihydroxycyclohexanones 12−15 from (−)-quinic acid based on radical allylation at the C4 position of methyl (−)-quinicate. The new type of the CD-ring coupling partner 23 was synthesized from 25-hydroxy Grundmann's ketone 19 to apply to the modified Julia olefination to construct a diene unit between the A-ring and the CD-ring. The coupling yields, including a deprotection step, were 47−62%. After the separation of the diastereomers based on C2 stereochemistry, the structure (2α or 2β) was determined by 1H NMR experiments and compared to DeLuca's 2-methyl- and 2-ethyl-1α,25-dihydroxy-19-norvitamin D3. Thus, the synthesized 2α-(3-hydroxypropyl)-1α,25-dihydroxy-19-norvitamin D3 (8a) showed almost the same potency in binding to the bovine thymus vitamin D receptor (VDR) as the natural hormone 1, while its β-isomer 8b had only a 3% affinity. Both 2α-allyl- and 2α-propyl-1α,25-dihydroxy-19-norvitamin D3 (6a and 7a) and their 2β-analogues (6b and 7b) possessed a weak affinity for the VDR. The strong VDR ligand 8a was ca. 36-fold more potent in induction of HL-60 cell differentiation than 1, and interestingly, even the weaker ligand 8b showed a 6.7-fold higher potency in the cell differentiation activity than that of 1.Keywords
This publication has 24 references indexed in Scilit:
- 2.ALPHA.-(3-Hydroxypropyl)- and 2.ALPHA.-(3-Hydroxypropoxy)-1.ALPHA.,25-dihydroxyvitamin D3 Accessible to Vitamin D Receptor Mutant Related to Hereditary Vitamin D-Resistant Rickets.CHEMICAL & PHARMACEUTICAL BULLETIN, 2003
- 2-Ethyl and 2-Ethylidene Analogues of 1α,25-Dihydroxy-19-norvitamin D3: Synthesis, Conformational Analysis, Biological Activities, and Docking to the Modeled rVDR Ligand Binding DomainJournal of Medicinal Chemistry, 2002
- A Rationale for Treatment of Hereditary Vitamin D-resistant Rickets with Analogs of 1α,25-Dihydroxyvitamin D3Journal of Biological Chemistry, 2001
- Highly potent cell differentiation-inducing analogues of 1α,25-dihydroxyvitamin D3: synthesis and biological activity of 2-methyl-1,25-dihydroxyvitamin D3 with side-chain modificationsBioorganic & Medicinal Chemistry, 2001
- History of the development of new vitamin D analogs: studies on 22-oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy)calcitriol (ED-71)Steroids, 2001
- New 1α,25-Dihydroxy-19-norvitamin D3 Compounds of High Biological Activity: Synthesis and Biological Evaluation of 2-Hydroxymethyl, 2-Methyl, and 2-Methylene AnaloguesJournal of Medicinal Chemistry, 1998
- Synthesis and Biological Activity of 2-Hydroxy and 2-Alkoxy Analogs of 1.alpha.,25-Dihydroxy-19-norvitamin D3Journal of Medicinal Chemistry, 1994
- Synthesis of two useful, enantiomerically pure derivatives of (S)-4-hydroxy-2-cyclohexenoneThe Journal of Organic Chemistry, 1989
- Global Sea Level and Earth RotationScience, 1988
- Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide.The Journal of Experimental Medicine, 1979